PIK3CA and PTEN hamartoma tumor syndrome: Furthermore, BCs from PHTS patients with germline pathogenic or likely pathogenic PTEN variants (Tier-1 variants), had much fewer somatic mutations in PIK3CA compared to those in TCGA and in PHTS-Tier 2 (variant of unknown significance or likely benign variants) BCs.